Monitoring Agency Report for the quarter ended 31st March 2026
GRASIM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
CARE Ratings Limited submitted its quarterly monitoring report for Grasim Industries' Rights Issue of ₹3,999.80 crore (opened January 17–29, 2024, at ₹1,812 per share). The issue was fully subscribed with 2,20,70,910 shares allotted aggregating ₹3,999.25 crore. The report confirms zero deviation in fund utilization — the ₹3,000 crore allocated for debt repayment/prepayment has been fully deployed, and ₹971.11 crore of the ₹977.65 crore general corporate purposes (GCP) allocation has been utilized with ₹0.42 crore remaining unutilized. The monitoring account holds ₹0.32 crore after the company deployed ₹1.40 crore of unutilized issue expenses toward GCP in Q4FY25. Promoter shareholding rose from 42.75% (pre-issue, December 2023) to 43.74% as of March 31, 2026. A pending ₹4.61 crore is yet to be collected from investors. No delays or material deviations were observed, and all expenditures align with the offer document disclosures.
The filing is positive — it confirms proper deployment of rights issue proceeds with no misuse or deviation, reinforcing accountability. No impact on the stock expected as this is a routine compliance confirmation. The slight promoter stake increase reflects the rights issue participation.